Blog & News

Join the networking with “Human Ingredients,” a new HR/TA event on November 28, in Nieuwegein. Dive into hot topics like Diversity & Inclusion and AI in recruitment over drinks and bites. Exclusively for Life Sciences’ HR professionals, this networking opportunity is for free with registration. Connect with peers and lead the change!

Has your business got what it takes to bounce back when the going gets tough? In this article, Talentmark discuss the importance of resilience from a human capital perspective. What are the pitfalls to avoid and what steps can you take to ensure that you can build back better? Click here to discover our latest insights.

Don’t miss out on the game-changing factors shaping the Life Sciences landscape. As we hit the six-month milestone for 2023, Talentmark explores some of the key challenges facing business leaders. We discuss how your business can strategically navigate this complexity, including resourcing issues. Click here to discover our latest insights.

The vital role that interim executives can play in the development of all companies, but particularly Life Sciences start-ups is well known.

Recent years have seen a much greater awareness of the reality of gender inequity in scientific research and a growing understanding of the importance of an inclusive and diverse approach.

As an executive search consultancy which sources senior regulatory affairs leaders, we’re constantly being asked to find talented people who combine the traditional strengths of the regulatory affairs professional with a broader skill-set – one that includes strategic planning and negotiation.

The U.S. Congress has just approved the Food and Drug Administration’s (FDA) new accelerated approval path. Accelerated approvals allow the agency to pass fast access to drugs for serious and life-threatening diseases by approving them based on test results which predict clinical outcomes.

There is still plenty of cash looking for a good home, but the criteria have changed. It’s no longer enough to have a good idea and this trend looks set to continue in the year ahead.

Thanks to its role in developing products and services that improve public health, the life sciences industry provides the purpose that is seen as so important to today’s investors and potential employees. As a result, it goes some way to fulfilling the criteria for the “social” aspect of the Environment …

As 2023 swings into gear, Talentmark are already out and about getting the inside-track on the key issues facing the life sciences industry. David Nolan has just returned from J.P. Morgan’s annual Healthcare Conference in San Francisco, the most informative healthcare investment and partnering symposium in the industry.

Why is it that so many life-sciences firms don’t use an executive search partner as an integral part of developing and delivering their growth strategy? One concern can be around resourcing costs and uncertainty about the return on investment.

It has been exciting to be on the ground at this year’s Cell & Gene Meeting on the Mesa in California and to hear about clinical and commercial progress in the field. My colleague, Peter Kaplan and I have had some very interesting discussions with senior executives and investors.